Dublin Core PKP Metadata Items Metadata for this Document
 
1. Title Title of document Diagnosis of drug-resistant TB and provision of second-line TB treatment in India: some ethical considerations
 
2. Creator Author's name, affiliation, country Jerome Amir Singh; Joint Centre for Bioethics and Dalla Lana School of Public Health, Sandra Rotman Centre, University Health Network, Toronto, Ontario; University of Toronto, Toronto, Ontario, Canada; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa; CA
 
3. Subject Discipline(s)
 
3. Subject Keyword(s)
 
4. Description Abstract Background: The GeneXpert® MTB/RIF (hereinafter Xpert) test has demonstrated sensitive detection of tuberculosis (TB) and Rifampicin resistance directly from untreated sputum in less than two hours. India is currently drafting the third phase of its Revised National Tuberculosis Control Programme (RNTCP). This process provides the country's health authorities with an ideal opportunity to revolutionise TB management in the country. The RNTCP is currently conducting a multi–site demonstration study to gather operational evidence to scale up the Xperttest under Indian programme conditions.
 
5. Publisher Organizing agency, location Forum for Medical Ethics Society
 
6. Contributor Sponsor(s)
 
7. Date (YYYY-MM-DD) 2016-11-30
 
8. Type Status & genre
 
8. Type Type
 
9. Format File format HTML , PDF
 
10. Identifier Uniform Resource Identifier https://ijme.in/articles/diagnosis-of-drug-resistant-tb-and-provision-of-second-line-tb-treatment-in-india-some-ethical-considerations/
 
11. Source Title; vol., no. (year) Indian Journal of Medical Ethics;: Scrutiny is the key
 
12. Language English=en en
 
13. Relation Supp. Files
 
14. Coverage Geo-spatial location, chronological period, research sample (gender, age, etc.)
 
15. Rights Copyright and permissions

All articles published in IJME are available on its website free of charge. The copyright for published material belongs to IJME/FMES. IJME freely permits the reprint (or reproduction on a website) of articles from the journal, as long as this is for non-commercial use and appropriate credit is given to the author and the journal and publication details are mentioned. The commercial use of our content can be made only after obtaining permission from and on payment to IJME. This is intended to support production of the journal.